Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01289
http://purl.obolibrary.org/obo/dinto_DB01289
|
|---|---|
| Preferred Name | glisoxepide |
| Synonyms |
C20H27N5O5S
N-{2-[4-({[(azepan-1-yl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-5-methyl-1,2-oxazole-3-carboxamide
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | glisoxepide
|
|---|---|
| label | glisoxepide
|
| ATCCode | A10BB11
|
| Definition | Glisoxepide is one of the sulphonamide-derived oral antidiabetic drugs. It inhibits the uptake of bile acids into isolated rat hepatocytes. However it inhibits taurocholate uptake only in the absence of sodium ions. Glisoxepide uptake could be further inhibited by blockers of the hepatocellular monocarboxylate transporter, by the loop diuretic bumetanide, by 4,4 -diisothiocyano-2,2 -stilbenedisulfonate (DIDS) and by sulphate. These results are consistent with the transport of glisoxepide via the transport system for the unconjugated bile acid cholate.
(PMID:1618280, 9017793)
|
| has pharmacological target | |
| inhibits | |
| type | |
| InChIKey | InChIKey=ZKUDBRCEOBOWLF-UHFFFAOYSA-N
|
| Synonym |
C20H27N5O5S
N-{2-[4-({[(azepan-1-yl)carbamoyl]amino}sulfonyl)phenyl]ethyl}-5-methyl-1,2-oxazole-3-carboxamide
|
| xref |
PubChem Compound:32778
PubChem Substance:46508780
PharmGKB:PA164743233
ChemSpider:30380
|
| CASRN | 25046-79-1
|
| prefixIRI | obo2:dinto_DB01289
|
| SMILES | CC1=CC(=NO1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN1CCCCCC1
|
| may interact with |
See more
See less
|
| InChI | InChI=1S/C20H27N5O5S/c1-15-14-18(23-30-15)19(26)21-11-10-16-6-8-17(9-7-16)31(28,29)24-20(27)22-25-12-4-2-3-5-13-25/h6-9,14H,2-5,10-13H2,1H3,(H,21,26)(H2,22,24,27)
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |